The clinical trials in nonneutropenic septic patients indicated that the use of G-CSF decreased the risk of sepsis in nosocomial pneumonia patients, although the effect did not reach statistical significance [ 24 ].
← all excerpts
Balancing Innate Immunity and Inflammatory State via Modulation of Neutrophil Function: A Novel Strategy to Fight Sepsis.
1
—
—